8/15/20 Update: COVID-19 Vaccine Candidates

Innovative platforms such as nucleic acid (DNA and RNA), virus-like particle, peptide, viral vector (replicating and non-replicating), recombinant protein, live attenuated virus, and, inactivated virus development studies are currently focused on producing a COVID-19 disease preventive vaccine. Update listing on this webpage.

Over 480 clinical trial, patient recruitment projects are sponsored by Antidote.